Pier Capital, LLC Axogen, Inc. Transaction History

Pier Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $3.82 Million - $8.54 Million	-223,369 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $2.41 Million - $3.95 Million	70,728 Added 46.34%	223,369 $8.23 Million
Q2 2018 Aug 08, 2018	BUY	$36.15 - $52.5 $5.52 Million - $8.01 Million	152,641 New	152,641 $7.67 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.